サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1420992

移植診断市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年～2031年

Transplant Diagnostics Market (Screening: Pre-transplant Diagnostics and Post-transplant Diagnostics; and Technique: Molecular Assay and Non-molecular Assay) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 295 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
移植診断市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年～2031年
出版日: 2023年12月14日
発行: Transparency Market Research
ページ情報: 英文 295 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

移植診断市場 - レポートの範囲

世界の移植診断市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、世界の移植診断市場の収益を提供します。 2017年から2031年の期間、2023年を基準年、2031年を予測年とみなします。このレポートは、2023年から2031年までの世界の移植診断市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、主要企業の製品文献、年次報告書、プレスリリース、および移植診断市場を理解するための関連文書の参照が含まれます。

市場スナップショット
2023年の市場価値 12億米ドル
2031年の市場価値 23億米ドル
CAGR 7.7%

このレポートは、世界の移植診断市場の競合情勢を詳しく調査しています。世界の移植診断市場で活動する主要企業が特定され、それぞれの企業がさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の移植診断市場の企業の属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017年～2031年

第5章 重要な洞察

  • パイプライン分析
  • 主要製品/ブランド分析
  • 主な合併と買収
  • COVID-19感染症のパンデミックが業界に与える影響

第6章 世界市場の分析と予測：スクリーニング別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：スクリーニング別、2017年～2031年
    • プレ
    • ポスト
  • 市場の魅力度：スクリーニング別

第7章 世界市場の分析と予測：手法別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：手法別、2017年～2031年
    • 分子アッセイ
    • 非分子アッセイ
    • 7.4市場の魅力：手法別

第8章 世界市場の分析と予測：用途別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：用途別、2017年～2031年
    • 固形臓器移植
      • 腎臓
      • 肝臓
      • 心臓
      • 肺
      • 膵臓
      • 小腸
    • 幹細胞移植
  • 市場の魅力：用途別

第9章 世界市場の分析と予測：製品・サービス別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：製品・サービス別、2017年～2031年
    • 試薬と消耗品
    • 機器
    • ソフトウェアとサービス
  • 市場の魅力度：製品・サービス別

第10章 世界市場の分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：エンドユーザー別、2017年～2031年
    • 病院と移植センター
    • 研究
    • その他
  • 市場の魅力度：エンドユーザー別

第11章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2017年～2031年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：地域別

第12章 北米市場の分析と予測

第13章 欧州市場の分析と予測

第14章 アジア太平洋市場の分析と予測

第15章 ラテンアメリカ市場の分析と予測

第16章 中東・アフリカ市場の分析と予測

第17章 競合情勢

  • 市場企業 - 競合マトリックス（企業の階層および規模別）
  • 市場シェア分析：企業別（2022年）
  • 企業プロファイル
    • Bio-Rad laboratories, Inc.
    • Qiagen NV
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific, Inc.
    • Becton, Dickinson and Company
    • Ortho Clinical Diagnostics
    • Immucor, Inc.
    • Illumina, Inc.
    • Siemens Healthineers（Siemens AG）
    • Agilent Technologies
図表

List of Tables

  • Table 01: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017-2031
  • Table 02: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 03: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017-2031
  • Table 04: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 05: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017-2031
  • Table 09: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 10: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 11: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017-2031
  • Table 12: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017-2031
  • Table 15: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 16: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 17: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017-2031
  • Table 18: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 19: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017-2031
  • Table 21: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 22: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 23: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017-2031
  • Table 24: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017-2031
  • Table 27: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 28: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 29: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017-2031
  • Table 30: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 31: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017-2031
  • Table 33: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 34: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 35: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017-2031
  • Table 36: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Transplant Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
  • Figure 02: Global Transplant Diagnostics Market Revenue (US$ Mn), by Screening, 2022
  • Figure 03: Global Transplant Diagnostics Market Value Share, by Screening, 2022
  • Figure 04: Global Transplant Diagnostics Market Revenue (US$ Mn), by Technique, 2022
  • Figure 05: Global Transplant Diagnostics Market Value Share, by Technique, 2022
  • Figure 06: Global Transplant Diagnostics Market Revenue (US$ Mn), by Application, 2022
  • Figure 07: Global Transplant Diagnostics Market Value Share, by Application, 2022
  • Figure 08: Global Transplant Diagnostics Market Revenue (US$ Mn), by Products & Services, 2022
  • Figure 09: Global Transplant Diagnostics Market Value Share, by Products & Services, 2022
  • Figure 10: Global Transplant Diagnostics Market Revenue (US$ Mn), by End-user, 2022
  • Figure 11: Global Transplant Diagnostics Market Value Share, by End-user, 2022
  • Figure 12: Global Transplant Diagnostics Market Value Share, by Region, 2022
  • Figure 13: Global Transplant Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 14: Global Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 15: Global Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023-2031
  • Figure 16: Global Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 17: Global Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 18: Global Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 19: Global Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 20: Global Transplant Diagnostics Market Revenue (US$ Mn), by Products & Services, 2022
  • Figure 21: Global Transplant Diagnostics Market Value Share, by Products & Services, 2022
  • Figure 22: Global Transplant Diagnostics Market Revenue (US$ Mn), by End-user, 2022
  • Figure 23: Global Transplant Diagnostics Market Value Share, by End-user, 2022
  • Figure 24: Global Transplant Diagnostics Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 25: Global Transplant Diagnostics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 26: North America Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 27: North America Transplant Diagnostics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 28: North America Transplant Diagnostics Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 29: North America Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 30: North America Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 31: North America Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 32: North America Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 33: North America Transplant Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031
  • Figure 34: North America Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023-2031
  • Figure 35: North America Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 36: North America Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 37: North America Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023-2031
  • Figure 38: North America Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 39: Europe Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 40: Europe Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 41: Europe Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 42: Europe Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 43: Europe Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 44: Europe Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 45: Europe Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 46: Europe Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 47: Europe Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023-2031
  • Figure 48: Europe Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 49: Europe Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 50: Europe Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023-2031
  • Figure 51: Europe Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 52: Asia Pacific Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 53: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 54: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 55: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 56: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 57: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 58: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 59: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 60: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023-2031
  • Figure 61: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 62: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 63: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023-2031
  • Figure 64: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 65: Latin America Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 66: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 67: Latin America Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 68: Latin America Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 69: Latin America Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 70: Latin America Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 71: Latin America Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 72: Latin America Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 73: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023-2031
  • Figure 74: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 75: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 76: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023-2031
  • Figure 77: Latin America Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 78: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 79: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 80: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 81: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 82: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 83: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 84: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 85: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 86: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023-2031
  • Figure 87: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 88: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 89: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023-2031
  • Figure 90: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
目次
Product Code: TMRGL20225

Transplant Diagnostics Market - Scope of Report

TMR's report on the global transplant diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global transplant diagnostics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global transplant diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the transplant diagnostics market.

Market Snapshot
Market Value in 2023US$ 1.2 Bn
Market Value in 2031US$ 2.3 Bn
CAGR7.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global transplant diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global transplant diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global transplant diagnostics market.

The report delves into the competitive landscape of the global transplant diagnostics market. Key players operating in the global transplant diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global transplant diagnostics market profiled in this report.

Key Questions Answered in Global transplant diagnostics Market Report:

  • What is the sales/revenue generated by transplant diagnostics across all regions during the forecast period?
  • What are the opportunities in the global transplant diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Transplant Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global transplant diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global transplant diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global transplant diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transplant Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Transplant Diagnostics Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Transplant Diagnostics Market Analysis and Forecast, by Screening

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Screening, 2017-2031
    • 6.3.1. Pre-transplant Diagnostics
    • 6.3.2. Post-transplant Diagnostics
  • 6.4. Market Attractiveness, by Screening

7. Global Transplant Diagnostics Market Analysis and Forecast, by Technique

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technique, 2017-2031
    • 7.3.1. Molecular Assay
    • 7.3.2. Non-molecular Assay
    • 7.3.3. 7.4 Market Attractiveness, by Technique

8. Global Transplant Diagnostics Market Analysis and Forecast, by Application

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2017-2031
    • 8.3.1. Solid Organ Transplantation
      • 8.3.1.1. Kidney
      • 8.3.1.2. Liver
      • 8.3.1.3. Heart
      • 8.3.1.4. Lungs
      • 8.3.1.5. Pancreas
      • 8.3.1.6. Small Bowel
    • 8.3.2. Stem Cell Transplantation
  • 8.4. Market Attractiveness, by Application

9. Global Transplant Diagnostics Market Analysis and Forecast, by Products & Services

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Products & Services, 2017-2031
    • 9.3.1. Reagents & Consumables
    • 9.3.2. Instruments
    • 9.3.3. Software & Services
  • 9.4. Market Attractiveness, by Products & Services

10. Global Transplant Diagnostics Market Analysis and Forecast, by End-user

  • 10.1. Introduction and Definitions
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Hospitals & Transplant Centers
    • 10.3.2. Research Laboratories
    • 10.3.3. Others
  • 10.4. Market Attractiveness, by End-user

11. Global Transplant Diagnostics Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region, 2017-2031
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness, by Region

12. North America Transplant Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Screening, 2017-2031
    • 12.2.1. Pre-transplant Diagnostics
    • 12.2.2. Post-transplant Diagnostics
  • 12.3. Market Attractiveness, by Screening
  • 12.4. Market Value Forecast, by Technique, 2017-2031
    • 12.4.1. Molecular Assay
    • 12.4.2. Non-molecular Assay
  • 12.5. Market Attractiveness, by Technique
  • 12.6. Market Value Forecast, by Application, 2017-2031
    • 12.6.1. Solid Organ Transplantation
      • 12.6.1.1. Kidney
      • 12.6.1.2. Liver
      • 12.6.1.3. Heart
      • 12.6.1.4. Lungs
      • 12.6.1.5. Pancreas
      • 12.6.1.6. Small Bowel
    • 12.6.2. Stem Cell Transplantation
  • 12.7. Market Attractiveness, by Application
  • 12.8. Market Value Forecast, by Products & Services, 2017-2031
    • 12.8.1. Reagents & Consumables
    • 12.8.2. Instruments
    • 12.8.3. Software & Services
  • 12.9. Market Attractiveness, by Products & Services
  • 12.10. Market Value Forecast, by End-user, 2017-2031
    • 12.10.1. Hospitals & Transplant Centers
    • 12.10.2. Research Laboratories
    • 12.10.3. Others
  • 12.11. Market Attractiveness, by End-user
  • 12.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.12.1. U.S.
    • 12.12.2. Canada
  • 12.13. Market Attractiveness Analysis
    • 12.13.1. By Screening
    • 12.13.2. By Technique
    • 12.13.3. By Application
    • 12.13.4. By Products & Services
    • 12.13.5. By End-user
    • 12.13.6. By Country

13. Europe Transplant Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Screening, 2017-2031
    • 13.2.1. Pre-transplant Diagnostics
    • 13.2.2. Post-transplant Diagnostics
  • 13.3. Market Attractiveness, by Screening
  • 13.4. Market Value Forecast, by Technique, 2017-2031
    • 13.4.1. Molecular Assay
    • 13.4.2. Non-molecular Assay
  • 13.5. Market Attractiveness, by Technique
  • 13.6. Market Value Forecast, by Application, 2017-2031
    • 13.6.1. Solid Organ Transplantation
      • 13.6.1.1. Kidney
      • 13.6.1.2. Liver
      • 13.6.1.3. Heart
      • 13.6.1.4. Lungs
      • 13.6.1.5. Pancreas
      • 13.6.1.6. Small Bowel
    • 13.6.2. Stem Cell Transplantation
  • 13.7. Market Attractiveness, by Application
  • 13.8. Market Value Forecast, by Products & Services, 2017-2031
    • 13.8.1. Reagents & Consumables
    • 13.8.2. Instruments
    • 13.8.3. Software & Services
  • 13.9. Market Attractiveness, by Products & Services
  • 13.10. Market Value Forecast, by End-user, 2017-2031
    • 13.10.1. Hospitals & Transplant Centers
    • 13.10.2. Research Laboratories
    • 13.10.3. Others
  • 13.11. Market Attractiveness, by End-user
  • 13.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.12.1. Germany
    • 13.12.2. U.K.
    • 13.12.3. France
    • 13.12.4. Italy
    • 13.12.5. Spain
    • 13.12.6. Rest of Europe
  • 13.13. Market Attractiveness Analysis
    • 13.13.1. By Screening
    • 13.13.2. By Technique
    • 13.13.3. By Application
    • 13.13.4. By Products & Services
    • 13.13.5. By End-user
    • 13.13.6. By Country/Sub-region

14. Asia Pacific Transplant Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Screening, 2017-2031
    • 14.2.1. Pre-transplant Diagnostics
    • 14.2.2. Post-transplant Diagnostics
  • 14.3. Market Attractiveness, by Screening
  • 14.4. Market Value Forecast, by Technique, 2017-2031
    • 14.4.1. Molecular Assay
    • 14.4.2. Non-molecular Assay
  • 14.5. Market Attractiveness, by Technique
  • 14.6. Market Value Forecast, by Application, 2017-2031
    • 14.6.1. Solid Organ Transplantation
      • 14.6.1.1. Kidney
      • 14.6.1.2. Liver
      • 14.6.1.3. Heart
      • 14.6.1.4. Lungs
      • 14.6.1.5. Pancreas
      • 14.6.1.6. Small Bowel
    • 14.6.2. Stem Cell Transplantation
  • 14.7. Market Attractiveness, by Application
  • 14.8. Market Value Forecast, by Products & Services, 2017-2031
    • 14.8.1. Reagents & Consumables
    • 14.8.2. Instruments
    • 14.8.3. Software & Services
  • 14.9. Market Attractiveness, by Products & Services
  • 14.10. Market Value Forecast, by End-user, 2017-2031
    • 14.10.1. Hospitals & Transplant Centers
    • 14.10.2. Research Laboratories
    • 14.10.3. Others
  • 14.11. Market Attractiveness, by End-user
  • 14.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.12.1. China
    • 14.12.2. Japan
    • 14.12.3. India
    • 14.12.4. Australia & New Zealand
    • 14.12.5. Rest of Asia Pacific
  • 14.13. Market Attractiveness Analysis
    • 14.13.1. By Screening
    • 14.13.2. By Technique
    • 14.13.3. By Application
    • 14.13.4. By Products & Services
    • 14.13.5. By End-user
    • 14.13.6. By Country/Sub-region

15. Latin America Transplant Diagnostics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Screening, 2017-2031
    • 15.2.1. Pre-transplant Diagnostics
    • 15.2.2. Post-transplant Diagnostics
  • 15.3. Market Attractiveness, by Screening
  • 15.4. Market Value Forecast, by Technique, 2017-2031
    • 15.4.1. Molecular Assay
    • 15.4.2. Non-molecular Assay
  • 15.5. Market Attractiveness, by Technique
  • 15.6. Market Value Forecast, by Application, 2017-2031
    • 15.6.1. Solid Organ Transplantation
      • 15.6.1.1. Kidney
      • 15.6.1.2. Liver
      • 15.6.1.3. Heart
      • 15.6.1.4. Lungs
      • 15.6.1.5. Pancreas
      • 15.6.1.6. Small Bowel
    • 15.6.2. Stem Cell Transplantation
  • 15.7. Stem Cell Transplantation Market Attractiveness, by Application
  • 15.8. Market Value Forecast, by Products & Services, 2017-2031
    • 15.8.1. Reagents & Consumables
    • 15.8.2. Instruments
    • 15.8.3. Software & Services
  • 15.9. Market Attractiveness, by Products & Services
  • 15.10. Market Value Forecast, by End-user, 2017-2031
    • 15.10.1. Hospitals & Transplant Centers
    • 15.10.2. Research Laboratories
    • 15.10.3. Others
  • 15.11. Market Attractiveness, by End-user
  • 15.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.12.1. Brazil
    • 15.12.2. Mexico
    • 15.12.3. Rest of Latin America
  • 15.13. Market Attractiveness Analysis
    • 15.13.1. By Screening
    • 15.13.2. By Technique
    • 15.13.3. By Application
    • 15.13.4. By Products & Services
    • 15.13.5. By End-user
    • 15.13.6. By Country/Sub-region

16. Middle East & Africa Transplant Diagnostics Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Screening, 2017-2031
    • 16.2.1. Pre-transplant Diagnostics
    • 16.2.2. Post-transplant Diagnostics
  • 16.3. Market Attractiveness, by Screening
  • 16.4. Market Value Forecast, by Technique, 2017-2031
    • 16.4.1. Molecular Assay
    • 16.4.2. Non-molecular Assay
  • 16.5. Market Attractiveness, by Technique
  • 16.6. Market Value Forecast, by Application, 2017-2031
    • 16.6.1. Solid Organ Transplantation
      • 16.6.1.1. Kidney
      • 16.6.1.2. Liver
      • 16.6.1.3. Heart
      • 16.6.1.4. Lungs
      • 16.6.1.5. Pancreas
      • 16.6.1.6. Small Bowel
    • 16.6.2. Stem Cell Transplantation
  • 16.7. Market Attractiveness, by Application
  • 16.8. Market Value Forecast, by Products & Services, 2017-2031
    • 16.8.1. Reagents & Consumables
    • 16.8.2. Instruments
    • 16.8.3. Software & Services
  • 16.9. Market Attractiveness, by Products & Services
  • 16.10. Market Value Forecast, by End-user, 2017-2031
    • 16.10.1. Hospitals & Transplant Centers
    • 16.10.2. Research Laboratories
    • 16.10.3. Others
  • 16.11. Market Attractiveness, by End-user
  • 16.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 16.12.1. GCC Countries
    • 16.12.2. South Africa
    • 16.12.3. Rest of Middle East & Africa
  • 16.13. Market Attractiveness Analysis
    • 16.13.1. By Screening
    • 16.13.2. By Technique
    • 16.13.3. By Application
    • 16.13.4. By Products & Services
    • 16.13.5. By End-user
    • 16.13.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 17.2. Market Share Analysis, by Company (2022)
  • 17.3. Company Profiles
    • 17.3.1. Bio-Rad laboratories, Inc.
      • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. Financial Overview
      • 17.3.1.4. SWOT Analysis
      • 17.3.1.5. Strategic Overview
    • 17.3.2. Qiagen N.V.
      • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. Financial Overview
      • 17.3.2.4. SWOT Analysis
      • 17.3.2.5. Strategic Overview
    • 17.3.3. F. Hoffmann-La Roche AG
      • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. Financial Overview
      • 17.3.3.4. SWOT Analysis
      • 17.3.3.5. Strategic Overview
    • 17.3.4. Thermo Fisher Scientific, Inc.
      • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.4.2. Product Portfolio
      • 17.3.4.3. Financial Overview
      • 17.3.4.4. SWOT Analysis
      • 17.3.4.5. Strategic Overview
    • 17.3.5. Becton, Dickinson and Company
      • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.5.2. Product Portfolio
      • 17.3.5.3. Financial Overview
      • 17.3.5.4. SWOT Analysis
      • 17.3.5.5. Strategic Overview
    • 17.3.6. Ortho Clinical Diagnostics
      • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.6.2. Product Portfolio
      • 17.3.6.3. Financial Overview
      • 17.3.6.4. SWOT Analysis
      • 17.3.6.5. Strategic Overview
    • 17.3.7. Immucor, Inc.
      • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.7.2. Product Portfolio
      • 17.3.7.3. Financial Overview
      • 17.3.7.4. SWOT Analysis
      • 17.3.7.5. Strategic Overview
    • 17.3.8. Illumina, Inc.
      • 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.8.2. Product Portfolio
      • 17.3.8.3. Financial Overview
      • 17.3.8.4. SWOT Analysis
      • 17.3.8.5. Strategic Overview
    • 17.3.9. Siemens Healthineers (Siemens AG)
      • 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.9.2. Product Portfolio
      • 17.3.9.3. Financial Overview
      • 17.3.9.4. SWOT Analysis
      • 17.3.9.5. Strategic Overview
    • 17.3.10. Agilent Technologies
      • 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.10.2. Product Portfolio
      • 17.3.10.3. Financial Overview
      • 17.3.10.4. SWOT Analysis
      • 17.3.10.5. Strategic Overview